Certolizumab Pegol for the Treatment of Chronic Plaque Psoriasis: DLQI and WPAI Patient-Reported Outcomes from Two Ongoing Phase 3, Multicenter, Randomized, Placebo-Controlled Studies (CIMPASI-1 and CIMPASI-2). J of Skin [Internet]. 2017 Oct. 27 [cited 2026 Apr. 20];1(3.1):s4. Available from: https://skin.dermsquared.com/skin/article/view/126